Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Oncology|November 12, 2005
A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancerChristos Kosmas, Nicolas Tsavaris, Aggelos Koutras, et al.
Medical Oncology (Northwood, London, England)|September 18, 2007
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II studyThomas Makatsoris, Pavlos Papakostas, Haralabos P Kalofonos, et al.
Journal of Chemotherapy (Florence, Italy)|December 13, 2007
Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancerA Onyenadum, H Gogas, C Markopoulos, et al.
Frontiers in Oncology|October 4, 2021
Genetic Variations of CD40 and LTβR Genes Are Associated With Increased Susceptibility and Clinical Outcome of Non-Small-Cell Carcinoma PatientsFoteinos-Ioannis D Dimitrakopoulos, Anna G Antonacopoulou, Anastasia E Kottorou, et al.
International Journal of Gastrointestinal Cancer|May 10, 2005
A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancerThomas Makatsoris, Haralabos P Kalofonos, Gerasimos Aravantinos, et al.
Journal of Chemotherapy (Florence, Italy)|June 2, 2006
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancerA Onyenadum, H Gogas, P Kosmidis, et al.
Rheumatology (Oxford, England)|April 29, 2020
An MRI study of immune checkpoint inhibitor-induced musculoskeletal manifestations myofasciitis is the prominent imaging findingDimitrios Daoussis, Pantelis Kraniotis, Alexandra Filippopoulou, et al.
Phytochemistry Reviews : Proceedings of the Phytochemical Society of Europe|March 7, 2022
Valorisation of algal biomass to value-added metabolites: emerging trends and opportunitiesV S Uma, Zeba Usmani, Minaxi Sharma, et al.
Journal of Clinical Medicine|May 30, 2019
Expression of Immune System-Related Membrane Receptors CD40, RANK, BAFFR and LTβR is Associated with Clinical Outcome of Operated Non-Small-Cell Lung Cancer PatientsFoteinos-Ioannis D Dimitrakopoulos, Anastasia E Kottorou, Anna G Antonacopoulou, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|November 26, 1999
Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factorsT Hatzis, E Cardamakis, E Drivalas, et al.
Pageof 11